SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (124)1/16/2002 12:23:18 PM
From: scaram(o)uche  Read Replies (1) of 598
 
If I get them, I'll post them. The presentation was cut and dry, professional. I can't remember why I couldn't make the breakout. Seems silly, in retro.

Despite fact that data won't appear until ASCO, they will move forward with hepatocellular Ca.

T607..... phase I took longer than expected due to lower than expected toxicity. Phase II trials likely to be for HCC, NHL and gut carcinomas.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News